(NASDAQ: GOVX) Geovax Labs's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 71.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.62%.
Geovax Labs's earnings in 2025 is -$25,309,002.On average, 6 Wall Street analysts forecast GOVX's earnings for 2026 to be -$32,343,196, with the lowest GOVX earnings forecast at -$51,526,917, and the highest GOVX earnings forecast at -$19,026,283.
In 2027, GOVX is forecast to generate $46,156,188 in earnings, with the lowest earnings forecast at -$29,111,253 and the highest earnings forecast at $201,179,551.